MedTrace Logo

Study of Prognostic Factors in Adult Lymphoblastic Lymphoma

NCT03571997 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-02-01

No results posted yet for this study

Summary

Retrospective observational study with systematic collection of data on filiation (age at diagnosis and sex), clinical data (IPI, ECOG, early response to chemotherapy, overall response to chemotherapy), biological (strain B or T, infiltration of the nervous system central \[CNS\], bone marrow \[MO\], lactate dehydrogenase (LDH) level at the time of diagnosis, as well as genetic patients included in the study, as well as the PETHEMA protocol used in the treatment of same patients The study will review the PETHEMA protocols from 2003 to the present

Conditions

  • Lymphoblastic Lymphoma

Sponsors & Collaborators

  • PETHEMA Foundation

    lead OTHER

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571997 on ClinicalTrials.gov